1. Home
  2. CRBP vs FNKO Comparison

CRBP vs FNKO Comparison

Compare CRBP & FNKO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corbus Pharmaceuticals Holdings Inc.

CRBP

Corbus Pharmaceuticals Holdings Inc.

HOLD

Current Price

$11.46

Market Cap

147.4M

Sector

Health Care

ML Signal

HOLD

Logo Funko Inc.

FNKO

Funko Inc.

HOLD

Current Price

$5.55

Market Cap

162.5M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRBP
FNKO
Founded
2009
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Recreational Games/Products/Toys
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
147.4M
162.5M
IPO Year
2014
2017

Fundamental Metrics

Financial Performance
Metric
CRBP
FNKO
Price
$11.46
$5.55
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
3
Target Price
$45.50
$6.00
AVG Volume (30 Days)
290.4K
705.1K
Earning Date
05-08-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,822,272.00
$908,209,000.00
Revenue This Year
N/A
$4.42
Revenue Next Year
$116.00
$6.50
P/E Ratio
N/A
N/A
Revenue Growth
97.62
N/A
52 Week Low
$6.73
$2.22
52 Week High
$20.56
$6.09

Technical Indicators

Market Signals
Indicator
CRBP
FNKO
Relative Strength Index (RSI) 69.55 77.15
Support Level $9.32 $2.88
Resistance Level $11.64 $5.64
Average True Range (ATR) 0.70 0.32
MACD 0.08 0.12
Stochastic Oscillator 91.59 71.05

Price Performance

Historical Comparison
CRBP
FNKO

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a clinical stage company focused on new therapies in oncology and obesity and is committed to helping people defeat serious illness by bringing inventive scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

About FNKO Funko Inc.

Funko Inc is an USA based pop culture consumer products company. It creates whimsical, fun, and different products that enable the customer to express their affinity for their favorite through the movie, TV show, video game, musician, or sports team. The company's current products are principally figures, fashion accessories, apparel, plush products, accessories, homewares, and NFTs. The company sells its products through a diverse network of retail customers across multiple retail channels, including specialty retailers, mass-market retailers, and e-commerce sites. The company generates the majority of its revenue from the core collectibles products.

Share on Social Networks: